218 related articles for article (PubMed ID: 2459037)
21. [Inducing conformational changes in thrombin by ligands as a way of regulating its activity].
Gershkovich AA
Biokhimiia; 1996 Jul; 61(7):1139-51. PubMed ID: 9035728
[TBL] [Abstract][Full Text] [Related]
22. Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy.
Brill-Edwards P; Van Ryn-McKenna J; Cai L; Ofosu FA; Buchanan MR
Thromb Haemost; 1992 Oct; 68(4):424-7. PubMed ID: 1448774
[TBL] [Abstract][Full Text] [Related]
23. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
[TBL] [Abstract][Full Text] [Related]
25. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
[TBL] [Abstract][Full Text] [Related]
26. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
27. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
Emerson TE; Fournel MA; Leach WJ; Redens TB
Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
[TBL] [Abstract][Full Text] [Related]
28. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
Soulier JP; Gozin D; Lerable J
Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
[TBL] [Abstract][Full Text] [Related]
30. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
31. Effect of a synthetic thrombin inhibitor MCI-9038 on experimental models of disseminated intravascular coagulation in rabbits.
Hara H; Tamao Y; Kikumoto R; Okamoto S
Thromb Haemost; 1987 Apr; 57(2):165-70. PubMed ID: 3603410
[TBL] [Abstract][Full Text] [Related]
32. Clinico-pharmacological studies with recombinant hirudin.
Markwardt F; Nowak G; Stürzebecher J; Vogel G
Thromb Res; 1988 Dec; 52(5):393-400. PubMed ID: 3222782
[TBL] [Abstract][Full Text] [Related]
33. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC).
Ishikawa A; Hafter R; Seemüller U; Gokel JM; Graeff H
Thromb Res; 1980 Aug; 19(3):351-8. PubMed ID: 7434319
[No Abstract] [Full Text] [Related]
34. Studies in experimental animals on disseminated intravascular coagulation (DIC).
Markwardt F; Nowak G; Meerbach W; Rüdiger KD
Thromb Diath Haemorrh; 1975 Nov; 34(2):513-21. PubMed ID: 1198409
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
36. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
37. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
38. A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.
Spannagl M; Hoffmann H; Siebeck M; Weipert J; Schwarz HP; Schramm W
Thromb Res; 1991 Jan; 61(1):1-10. PubMed ID: 2020936
[TBL] [Abstract][Full Text] [Related]
39. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the de-endothelialized rabbit aorta in vitro.
Hatton MW; Moar SL
Thromb Haemost; 1991 Aug; 66(2):208-12. PubMed ID: 1771613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
